Immunodiagnostics Market Research, Size, Share, Growth, Demand, Major Companies And Forecast 2033

The immunodiagnostics market size has grown strongly in recent years. It will grow from $21.3 billion in 2023 to $22.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing incidence of infectious diseases, rise in autoimmune diseases, cancer diagnosis and monitoring, globalization of infectious diseases, public health initiatives and screening programs.

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $30.9 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to pandemic preparedness and response, personalized medicine and biomarker discovery, growing healthcare infrastructure in emerging markets, integration with laboratory information systems, rising burden of chronic diseases. Major trends in the forecast period include multiplexing technologies, point-of-care testing (poct), biomarker discovery and personalized medicine, rise of digital immunodiagnostics, shift towards liquid biopsy.

Market Overview -
Immunodiagnostics refers to a diagnostic methodology that relies primarily on an antigen-antibody response for the detection of serum insulin. Immunodiagnostic tests are used to detect antibodies and parasite antigens.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Rising Prevalence Of Infectious Diseases Propelling Immunodiagnostics Market Growth
The increasing prevalence of infectious diseases is expected to boost the growth of the immunodiagnostics market going forward. Infectious diseases refer to illnesses that transmit between people and are brought on by germs like viruses, bacteria, fungi, or parasites. An immunodiagnostic assay is used to identify a virus present in a blood sample. Hence, the increasing prevalence of infectious diseases is expected to boost the immunodiagnostics market. For instance, in July 2022, according to a report published by the Australian Institute of Health and Welfare, an Australia-based statutory agency that offers data and statistics about Australia's well-being and health, there were over 471,000 COVID-19 cases reported in Australia in 2021. Further, in 2021, there were around 86,000 cases of chlamydia, a sexually transmitted infection, and cases of campylobacter, a gastrointestinal illness, increased to 37,000. Therefore, the increasing prevalence of infectious diseases is driving the growth of the immunodiagnostics market.

Competitive Landscape -
Major companies operating in the immunodiagnostics market report are Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

Revolutionizing Immunodiagnostics With Technological Advancements In Healthcare Sector
Technological advancement is the key trend gaining popularity in the immunodiagnostics market. Major companies operating in the immunodiagnostics market are focusing on developing new technologies to sustain their market position. For instance, in May 2021, Cavidi AB, a Sweden-based developer and supplier of viral load solutions for human immunodeficiency virus (HIV) monitoring, launched Exazym, a signal-generating technology to bring ultra-sensitive detection levels to conventional immunodiagnostic assays. The signal-generating technology, allows traditional immunodiagnostic procedures to achieve ultra-sensitive detection levels. Cavidi Exazym is anticipated to improve present and future research, health screenings, and diagnostic testing. The use of Cavidi Exazym enables the detection of biomarkers that are outside the scope of available diagnostic techniques, enabling medical professionals to start treating patients even before the beginning of a serious illness.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Key Segments -
The immunodiagnostics market covered in this report is segmented -
1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.